Eli Lilly
Trade Eli Lilly 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About LLY
Eli Lilly & Co. engages in the discovery, development, manufacture, and sale of pharmaceutical products. The firm's products include diabetes, oncology, immunology, neuroscience, and other products and therapies.
LLY Key Statistics
Stock Snapshot
With a market cap of 1.18T, Eli Lilly(LLY) trades at $1,253.98. The stock has a price-to-earnings ratio of 42.71 and currently yields dividends of 0.53%.
During the trading session on 2026-10-19, Eli Lilly(LLY) shares reached a daily high of $1,259.75 and a low of $1,240.23. At a current price of $1,253.98, the stock is +1.1% higher than the low and still -0.5% under the high.
Trading activity shows a volume of 350.49K, compared to an average daily volume of 2.33M.
The stock's 52-week range extends from a low of $783.85 to a high of $1,292.65.
The stock's 52-week range extends from a low of $783.85 to a high of $1,292.65.
LLY News
The weight-loss market is growing rapidly, and while long-term projections differ on how large it will become, they generally agree that it will maintain its up...
These 7 Stocks Are Analyst Favorites For Magnificent Earnings Growth; Eli Lilly Leads Industry 10/17/2026 Among the best stocks in earnings performance, highly...
Analyst Jason Gerberry of Bank of America Securities reiterated a Buy rating on Eli Lilly & Co, boosting the price target to $1,397.00. Jason Gerberry has give...
Analyst ratings
85%
of 33 ratingsMore LLY News
METiS TechBio announced a strategic collaboration with Eli Lilly (LLY) and Company focused on the research and discovery of novel lipid nanoparticle-based deliv...
An update from Metis TechBio Co., Ltd. Class H ( (HK:7666) ) is now available. Metis TechBio has entered a strategic collaboration with Eli Lilly to research a...
Eli Lilly (LLY) announced late-breaking one-year results from the Phase 3 SHINE-2 study of Omvoh in pediatric patients ages 6 to 17 with moderately to severely...
Eli Lilly (LLY) and Company announced that new data from across its oncology portfolio will be presented at the European Society for Medical Oncology, ESMO, Con...
has turned into one of the most closely watched stocks in healthcare after a powerful multi‑year rally. That naturally raises a blunt question for anyone lookin...
Eli Lilly's (LLY +0.27%) Zepbound, an anti-obesity medicine, was first approved in the U.S. in 2023. It has become one of the company's main growth drivers ever...
Investing A $1,000 Investment in Eli Lilly Became $18,637. The Obesity Boom Changed Everything Eli Lilly spent most of its 150-year history as a quiet insulin m...
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.